Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma.
about
Neoadjuvant chemotherapy in oral cancers: Selecting the right patientsPatient-derived xenograft platform of OSCC: a renewable human bio-bank for preclinical cancer research and a new co-clinical model for treatment optimization.Clinical and prognostic significance of HIF-1α overexpression in oral squamous cell carcinoma: a meta-analysis.Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma.Efficacy and toxicity of docetaxel combination chemotherapy for advanced squamous cell cancer of the head and neck.Low Annexin A1 expression predicts benefit from induction chemotherapy in oral cancer patients with moderate or poor pathologic differentiation gradeLactate dehydrogenase B is associated with the response to neoadjuvant chemotherapy in oral squamous cell carcinomaPrognostic Role of Circulating Tumor Cells during Induction Chemotherapy Followed by Curative Surgery Combined with Postoperative Radiotherapy in Patients with Locally Advanced Oral and Oropharyngeal Squamous Cell Cancer.Anterior gradient protein 2 expression in high grade head and neck squamous cell carcinoma correlated with cancer stem cell and epithelial mesenchymal transition.Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1-miR-593-5p-MFF axis.CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancerLong-term results of a randomized phase III trial of TPF induction chemotherapy followed by surgery and radiation in locally advanced oral squamous cell carcinoma.STAT3 blockade enhances the efficacy of conventional chemotherapeutic agents by eradicating head neck stemloid cancer cell.Betel nut chewing history is an independent prognosticator for smoking patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil.NOTCH1 inhibition enhances the efficacy of conventional chemotherapeutic agents by targeting head neck cancer stem cell.Hypoxia induces TFE3 expression in head and neck squamous cell carcinomaNeoadjuvant chemotherapy followed by surgery has no therapeutic advantages over concurrent chemoradiotherapy in International Federation of Gynecology and Obstetrics stage IB-IIB cervical cancer.Definitive chemoradiation for primary oral cavity carcinoma: A single institution experience.Elevated cyclin D1 expression is predictive for a benefit from TPF induction chemotherapy in oral squamous cell carcinoma patients with advanced nodal disease.Oral Cavity Carcinoma: Current Management, Controversies, and Future Directions.Histopathological assessment of tumour regression, nodal stage and status of resection margins determines prognosis in patients with oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy.Outcome of Neoadjuvant Chemotherapy on Local Recurrence and Distant Metastasis of Oral Squamous Cell Carcinoma: A Retrospective Study.A novel prognostic index for oral squamous cell carcinoma patients with surgically treated.Expression of VISTA correlated with immunosuppression and synergized with CD8 to predict survival in human oral squamous cell carcinoma.LAG-3 confers poor prognosis and its blockade reshapes antitumor response in head and neck squamous cell carcinoma.Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond.Elevated level of serum growth differentiation factor 15 is associated with oral leukoplakia and oral squamous cell carcinoma.Clinical study on collagen gel droplet-embedded culture drug sensitivity test for multidrug combination chemotherapy and super selective intra-arterial infusion chemoradiotherapy in oral squamous cell carcinoma.Induction Chemotherapy in Technically Unresectable Locally Advanced T4a Oral Cavity Squamous Cell Cancers: Experience from a Regional Cancer Center of South India.Prognostic importance of pathological response to neoadjuvant chemotherapy followed by definitive surgery in advanced oral squamous cell carcinoma.Chemotherapy-Induced Long Non-coding RNA 1 Promotes Metastasis and Chemo-Resistance of TSCC via the Wnt/β-Catenin Signaling Pathway.AURKA is a predictor of chemotherapy response and prognosis for patients with advanced oral squamous cell carcinoma.Residual neck disease management in squamous-cell carcinoma of the head and neck treated with radiotherapy plus cetuximab.Thymosin β4 induces proliferation, invasion, and epithelial-to-mesenchymal transition of oral squamous cell carcinoma.Taxane-containing induction chemotherapy followed by definitive chemoradiotherapy. Outcome in patients with locally advanced head and neck cancer.Significance of mammalian target of rapamycin in patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil.Elevated growth differentiating factor 15 expression predicts long-term benefit of docetaxel, cisplatin and 5-fluorouracil induction chemotherapy in patients with oral cancer.A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in p
P2860
Q26768434-02F38709-1322-4389-985B-3A3322576071Q33457995-86BF5B55-6B44-41DE-9394-878CBBAA4891Q33706337-A71CDB9A-8700-4469-8175-7DD94C766957Q33771631-5F9727E0-0E2A-4CA4-AC91-8F49CE422417Q33858049-522D2AB7-D101-4CB0-BE54-EFB697AC210EQ34779430-EFF0A4B3-A910-445D-990B-27F7250F6334Q35606525-780C6D49-56CB-43EA-949A-69DA0AD0FADBQ35694837-585703A2-B0B6-4505-BFBC-ABBAF8B3D970Q35832228-F3FA0D1E-5F73-462B-B810-F0636BF81518Q36020872-027529A5-8EBC-4B48-9F31-24A019696BF1Q36172019-10E367AF-B629-4AAD-9249-3630991E89E7Q36210999-695D9DBF-D52F-49B2-8B6F-74B108A72DD5Q36561640-407A4A27-39E9-40B7-9DF1-4AD2170A851AQ36714584-B5CA18FD-1BBE-482A-A617-C583C59ECE85Q36830276-EFDDCA51-38F7-4649-A3E0-4CA527F8CCB0Q36998335-E0891224-772B-4DBE-BEA6-F6256C236787Q37092796-BE2E42F2-682C-48AE-B43E-244CFE0861E6Q37156582-1B5B2C4E-F664-4028-892E-743147A52EFDQ37594771-5CFFCFDE-88AE-4990-9575-C8BC917B8A85Q37658802-E6B237BB-ADE3-433A-B26D-151C7903815BQ39405849-DAAD72F6-09D8-4C33-8D01-0CF8C8463E7BQ39415046-8437E068-DB2F-4D49-947D-8C435F262DD4Q40043129-D1C8FE69-9CEF-4551-8ECC-AE5A8C4D8D09Q40446457-5D029EDB-1288-4577-8F14-552CC8D9AD24Q41997200-734220C4-0FF3-4E24-BE83-DF27DBA9E0C8Q43234029-55919812-C2DB-4F50-81EA-1B5098741EF3Q43833419-FEE46D99-85FF-41A4-92CC-F9E4ECED5938Q47143845-DE71E95E-2BA0-499F-80B2-00BFBEFF9396Q49401203-CD75B81D-FE1E-4A1F-90F5-B2B915EC6E18Q49556301-8F6E75A1-026D-4DFB-8E43-407679192CCAQ52560414-7665AB2B-525C-4D9C-997B-5BF96D001B72Q52979603-BC8D0646-5715-423D-A5FA-AB03A2597138Q52984459-CE2AB026-48AA-46F5-8AD2-C94C7612D630Q53215125-9E60EB72-D309-43EB-AB67-AC72C4284655Q54125631-6D1C6FAA-4B05-4F98-9F16-96432976AFA8Q54275299-8D051199-3E1B-488A-959E-266327CED418Q55284651-C1886FE8-887A-4B9D-9C84-F7490EBA708AQ58903143-FA1483C2-7772-410A-877D-271D8303CEC5
P2860
Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Randomized phase III trial of ...... oral squamous cell carcinoma.
@en
type
label
Randomized phase III trial of ...... oral squamous cell carcinoma.
@en
prefLabel
Randomized phase III trial of ...... oral squamous cell carcinoma.
@en
P2093
P2860
P356
P1476
Randomized phase III trial of ...... oral squamous cell carcinoma.
@en
P2093
Bo-song Wang
Chen-ping Zhang
Guo-xin Ren
Han-guang Zhu
J Jack Lee
Jeffrey N Myers
Lai-ping Zhong
P2860
P304
P356
10.1200/JCO.2012.43.8820
P407
P577
2012-11-05T00:00:00Z